Year: 2015
Type: editorial
Abstract: As exemplified by the accompanying research article, next‐generation sequencing of bladder tumors for clinical decision making facilitates the use of targeted therapies in advanced bladder cancer, a historically underresearched area of oncology. The overall benefit of targeted therapy in bladder cancer remains to be determined, but research efforts are underway.
Source: Cancer
DOI: 10.1002/cncr.29825
Authors: Angela K. Green, Matthew I. Milowsky
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2190723233
